Piper Sandler Initiates Coverage on Opus Genetics, Inc. (IRD) With “Overweight” Rating and $7 PT

by | Nov 30, 2025 | Uncategorized

Written By

Written by Albert Pham, News Curator and Blogger

Related Posts

0 Comments